Somwar, Romel
Hofmann, Nicolle E.
Smith, Bryan
Odintsov, Igor
Vojnic, Morana http://orcid.org/0000-0001-5441-4119
Linkov, Irina
Tam, Ashley http://orcid.org/0000-0002-5244-8806
Khodos, Inna
Mattar, Marissa S.
de Stanchina, Elisa
Flynn, Daniel
Ladanyi, Marc
Drilon, Alexander http://orcid.org/0000-0001-6806-9061
Shinde, Ujwal
Davare, Monika A. http://orcid.org/0000-0003-1802-7597
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U54 OD020355)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (2P30CA008748-48)
Article History
Received: 24 April 2020
Accepted: 20 November 2020
First Online: 16 December 2020
Competing interests
: The authors declare the following competing interests: N.E.H., I.O., M.V., I.L., M.S.M., E.d.S., A.T., U.S., and I.K. report no conflict of interest to disclose. Romel Somwar has received research funding from LOXO Oncology, Helsinn Healthcare, Merus, and Elevation Oncology to perform studies not related to this manuscript. Alexander Drilon is a consultant for Ignyta, LOXO Oncology, TP Therapeutics, AstraZeneca, Pfizer, Blueprint Medicines, Genentech, Roche, Takeda, Ariad, Millenium, Helsinn Healthcare, Eli Lilly, Bayer, Beigene, BergenBio, Hengrui Therapeutics, Exelixis, Tyra Biosciences, Verastem, MORE Health, Abbvie, 14ner/Elevation Oncology, ArcherDX, EMD Serono, Melendi, Monopteros, Novartis, Remedica Ltd., and Tyra Biosciences, and has received research funding from Foundation Medicine. He also received research support paid to Memorial Sloan Kettering Cancer Center from Pfizer, Exelixis, GlaxoSmithKlein, Teva, Taiho, and PharmaMar. Marc Ladanyi has received advisory board compensation from Boehringer Ingelheim, AstraZeneca, Bristol-Myers Squibb, Takeda, and Bayer, and research support from LOXO Oncology, Helsinn Healthcare, Elevation Oncology, and Merus. Bryan Smith and Daniel Flynn are full-time employees and own stock/options in Deciphera Pharmaceuticals. Monika A. Davare received research funding from Deciphera Pharmaceuticals that supported a subset of experiments in this manuscript.